Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (3)
  • Antibiotic
    (2)
  • DNA/RNA Synthesis
    (1)
  • HCV Protease
    (1)
  • Histone Methyltransferase
    (1)
  • c-Fms
    (1)
  • Others
    (4)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FACS
    (1)
  • Functional assay
    (1)
TargetMol | Tags By ResearchField
  • Infection
    (4)
  • Cancer
    (2)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

neutropenia

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Oligonucleotides
    1
    TargetMol | All_Pathways
Meropenem
SM 7338
T022496036-03-2
Meropenem (SM 7338) is a broad-spectrum carbapenem antibiotic administered intravenously for severe bacterial infections caused by sensitive agents. It commonly causes mild, transient aminotransferase elevations and can rarely lead to clinically apparent cholestatic liver injury.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
Meropenem trihydrate
SM 7338 trihydrate
T12004119478-56-7
Meropenem trihydrate (SM 7338 trihydrate) is a carbapenem antibiotic with broad-spectrum antibacterial activity.
  • $37
In Stock
Size
QTY
Balapiravir
Ro 4588161, R1626
T14493690270-29-2
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m
  • $112
5 days
Size
QTY
PRMT5-IN-53
T213001
PRMT5-IN-53 is an orally active, gut-restricted PRMT5 inhibitor, exhibiting pIC50 values of ≥ 9.7 against both hPRMT5 and mPRMT5. It binds to the PRMT5:MEP50 complex with a KD of 11.3 pM. In mice, PRMT5-IN-53 effectively inhibits intestinal PRMT5, significantly reducing both the number and size of polyps while avoiding systemic hematologic toxicity such as anemia and neutropenia. This compound is applicable in colorectal cancer research, particularly for familial adenomatous polyposis (FAP).
  • Inquiry Price
Inquiry
Size
QTY
SB 247464
T213501212077-57-1
SB 247464 is an orally active non-peptide ligand. It selectively activates the granulocyte colony-stimulating factor (G-CSF) signaling pathway in mice, mimicking the biological functions of G-CSF. SB 247464 is useful in the study of neutropenia and other diseases.
  • Inquiry Price
10-14 weeks
Size
QTY
LasR-IN-2
T61581
LasR-IN-2, a compound that inhibits the activity of LasR, forms hydrogen bonding with the TRY-56 residue. It finds application in the study of bacterial infection, neutropenia, severe burns, and chronic lung disease in cystic fibrosis (CF) [1].
  • $1,520
10-14 weeks
Size
QTY
Thenalidine tartrate
T695162784-55-6
Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug. It was withdrawn from the US, Canadian, and UK markets due to a risk of neutropenia. Thenalidine is an antagonist of the H1-receptor.
  • $1,520
6-8 weeks
Size
QTY
Eflapegrastim
T771721384099-30-2
Eflapegrastim, a humanized IgG4 monoclonal antibody and granulocyte colony-stimulating factor (G-CSF), targets the G-CSF receptor (c-Fms). It promotes the proliferation and differentiation of neutrophil progenitor cells, ensuring a stable count of mature and functional neutrophils, and effectively shortens the duration of neutropenia [1].
  • Inquiry Price
Inquiry
Size
QTY